The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Synchron has raised $200 million to support ...

After years of focusing on all things artificial intelligence, the buzziest buzz in medtech now centers not on robots and algorithms, but on the distinctly non-artificial abilities of the human brain.

The neurotech startup Synchron is building a brain implant to try and help patients with paralysis control their phones, computers and other devices with their minds. The company announced Thursday ...

In 2019, Elon Musk brought his latest high-tech venture out of the shadows, unveiling plans for an implanted brain chip that would be capable of simultaneously tracking and stimulating neurological ...

Brain-computer interfaces have become a practical (if limited) reality in the US. Synchron says it has become the first in the country to implant a BCI in a human patient. Doctors in New York's Mount ...

Synchron is part of an emerging crop of companies testing technology in the brain-computer interface industry. The system is implanted through the blood vessels and allows patients to operate ...

Thanks to the success of an initial safety trial for an implantable device that can translate the brain’s electrical impulses into readable signals, we’re a step closer to being able to text—or ...

Dr. Tom Oxley visibly stiffens at the prospect of using brain-computer interface technology for something as gauche as augmenting able-bodied humans. “We're not building a BCI to control Spotify or to ...

Exciting startup Synchron offers a revolutionary brain-computer interface solution for people with paralysis and other conditions Clinical trial demonstrates their non-invasive brain procedure could ...

Synchron Inc, a rival to Elon Musk’s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company ...

NEW YORK--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of neurotechnology.